Delivery Order SPE2DB24D1021-SPE2DB25FFAAP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lidocaine 5% Patch 30-count units, valued at $1,134.20. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $5,556.22. This is a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is not subject to any small business set-aside designation and represents a competitively awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30s at a ceiling value of $6,861.83. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order is scheduled for completion by August 14, 2025,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units with a ceiling value of $3,038.31. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for Lidocaine 5% Patch 30-count units with a ceiling value of $26,828.37. This firm fixed-price delivery order, which is due for completion by August 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $8,028.28. This competitively awarded, non-set-aside order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order carries a firm fixed price structure with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $1,622.36, represents a non-competitive set-aside contract and is scheduled for completion by August 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with a ceiling value of $5,186.72 under a firm fixed price contract. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its Corporate Office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,504.37 for Lidocaine 5% Patch (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $13,771.20. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAAPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for Lidocaine 5% Patch 30-count units with a ceiling value of $1,164.11. This firm fixed price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract was competitively awarded with no set-aside designation, and performance will be completed by August 28, 2025, at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies comprehensive pharmaceutical products and medical supplies to support federal military and veteran healthcare systems worldwide. This delivery order exemplifies the company's role as a critical vendor within DLA's Medical Supply Chain, providing pain management pharmaceuticals and specialized medical commodities across multiple therapeutic domains. The contract reflects AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through its established relationship with the Defense Logistics Agency and its position as a prime vendor for the Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/27/25 |